Engineering of acidic pH-responsive anti-CD3 binding antibodies
Artículo
Acceso abierto
Artículo
DOAJ
The development of anti-CD3 antibody-based T cell engager therapeutics has improved the treatment of various malignancies, yet the challenge of achieving tumor-specific targeting while minimizing on-target off-tumor effe...
LCC LCC:Therapeutics. Pharmacology; LCC:Immunologic diseases. AllergyIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access